Table 1.
Reasons for immunization by sex in the study population during the 2009/2010 national pharmacovigilance survey.
| Sex Target population (*) |
Male (% by sex) |
Female (% by sex) |
N
(% among 1000 subjects) |
|---|---|---|---|
| Healthcare workers | 253 (63.2%) | 147 (36.8%) | 400 (40.0%) |
| Subjects with diabetic | 211 (46.9%) | 237 (52.8%) | 449 (44.9%) |
| Subjects with chronic respiratory diseases | 20 (52.6%) | 18 (47.4%) | 38 (3.8%) |
| Subjects with other chronic diseases | 14 (35.9%) | 24 (61.5%) | 39 (3.9%) |
| Pregnant women | 0 (0.0%) | 67 (100.0%) | 67 (6.7%) |
| Children from 6 to 23 months | 8 (40.0%) | 12 (60.0%) | 20 (2.0%) |
| Healthy subjects | 39 (57.4%) | 29 (42.6%) | 68 (6.8%) |
(*) The categories are not mutually exclusive.